News Releases
Moat Biotechnology Is BSV’s Latest Investment
Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.
VC firm's latest portfolio company conveniently delivers science-backed support to postpartum mothers.
Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.
Leading regional bank applauds VC firm's efforts to support innovative founders struggling for funding.
Biotech firm aims to halt the progression of multiple sclerosis.